IDV vehicle
36C24226D0031
THIS TESTING IS ESSENTIAL TO PROPERLY MATCH ORGAN DONORS WITH RECIPIENTS, TO DECREASE REJECTION AND INCREASE LONGEVITY OF GRAFT FUNCTION. THIS TISSUE TYPING IS ALSO CRITICAL TO DIAGNOSING AND PREVENTING TRANSPLANT REJECTION.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 242-NETWORK CONTRACT OFFICE 02 (36C242) |
| NAICS | 621511 — Medical Laboratories |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $2.0M |
| Start date | Jun 1, 2026 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | May 27, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 27, 2026 | 0 | $0 | THIS TESTING IS ESSENTIAL TO PROPERLY MATCH ORGAN DONORS WITH RECIPIENTS, TO DECREASE REJECTION AND INCREASE LONGEVITY OF GRAFT FUNCTION. THIS TISSUE TYPING IS ALSO CRITICAL TO DIAGNOSING AND PREVENTING TRANSPLANT REJECTION. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.